BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 9751114)

  • 41. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
    Shapiro DN; Houghton PJ; Hazelton BJ; Germain GS; Murti KG; Rahman A; Houghton JA
    Cancer Res; 1990 Sep; 50(18):6002-9. PubMed ID: 2203524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
    Bailey P; Downes M; Lau P; Harris J; Chen SL; Hamamori Y; Sartorelli V; Muscat GE
    Mol Endocrinol; 1999 Jul; 13(7):1155-68. PubMed ID: 10406466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wild-type myoblasts rescue the ability of myogenin-null myoblasts to fuse in vivo.
    Myer A; Wagner DS; Vivian JL; Olson EN; Klein WH
    Dev Biol; 1997 May; 185(2):127-38. PubMed ID: 9187078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhabdomyosarcoma-specific expression of the herpes simplex virus thymidine kinase gene confers sensitivity to ganciclovir.
    Morton CL; Potter PM
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1066-73. PubMed ID: 9694970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein.
    Caruso M; Martelli F; Giordano A; Felsani A
    Oncogene; 1993 Feb; 8(2):267-78. PubMed ID: 8381218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stable expression of antisense Rb-1 RNA inhibits terminal differentiation of mouse myoblast C2 cells.
    Kobayashi M; Yamauchi Y; Tanaka A
    Exp Cell Res; 1998 Feb; 239(1):40-9. PubMed ID: 9511723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional down-regulation of myogenin expression is associated with v-ras-induced block of differentiation in unestablished quail muscle cells.
    Russo S; Tatò F; Grossi M
    Oncogene; 1997 Jan; 14(1):63-73. PubMed ID: 9010233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Jun inhibits myogenic differentiation.
    Su HY; Bos TJ; Monteclaro FS; Vogt PK
    Oncogene; 1991 Oct; 6(10):1759-66. PubMed ID: 1656361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced expression of mouse c-ski accompanies terminal skeletal muscle differentiation in vivo and in vitro.
    Namciu S; Lyons GE; Micales BK; Heyman HC; Colmenares C; Stavnezer E
    Dev Dyn; 1995 Nov; 204(3):291-300. PubMed ID: 8573720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin.
    Szalay K; Rázga Z; Duda E
    Eur J Cell Biol; 1997 Dec; 74(4):391-8. PubMed ID: 9438136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pkn is a novel partner of cyclin T2a in muscle differentiation.
    Cottone G; Baldi A; Palescandolo E; Manente L; Penta R; Paggi MG; De Luca A
    J Cell Physiol; 2006 Apr; 207(1):232-7. PubMed ID: 16331689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
    Wilson EM; Tureckova J; Rotwein P
    Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD; Reagan SR; Mahadevan MS
    J Cell Biol; 2002 Nov; 159(3):419-29. PubMed ID: 12427866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of cell history on response to helix-loop-helix family of myogenic regulators.
    Schäfer BW; Blakely BT; Darlington GJ; Blau HM
    Nature; 1990 Mar; 344(6265):454-8. PubMed ID: 2157160
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Administration of insulin to newly hatched chicks improves growth performance via impairment of MyoD gene expression and enhancement of cell proliferation in chicken myoblasts.
    Sato K; Aoki M; Kondo R; Matsushita K; Akiba Y; Kamada T
    Gen Comp Endocrinol; 2012 Feb; 175(3):457-63. PubMed ID: 22172340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MyoD transactivates angiotensinogen promoter in fibroblast C3H10T1/2 cells.
    Goswami SK; Zhao YY; Siddiqui MA; Kumar A
    Cell Mol Biol Res; 1993; 39(2):125-30. PubMed ID: 8220582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles.
    Ishido M; Kami K; Masuhara M
    Acta Physiol Scand; 2004 Mar; 180(3):281-9. PubMed ID: 14962010
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis.
    Graf Finckenstein F; Shahbazian V; Davicioni E; Ren YX; Anderson MJ
    Oncogene; 2008 Mar; 27(14):2004-14. PubMed ID: 17922034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of myostatin reduces MyoD induced myogenic potential of primary muscle fibroblasts.
    Shenoy P S; Bose B; Sharma M; McFarlane C; Kambadur R
    J Cell Biochem; 2014 Nov; 115(11):1908-17. PubMed ID: 24909401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.
    Sorrentino V; Pepperkok R; Davis RL; Ansorge W; Philipson L
    Nature; 1990 Jun; 345(6278):813-5. PubMed ID: 2359457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.